This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Former Advanz lawyer sets out antitrust compliance credentials as UK drug-pricing appeals kick off

By Simon Zekaria ( November 22, 2022, 17:39 GMT | Insight) -- Advanz Pharma's former top lawyer told a UK judge today that he was well versed in antitrust compliance in the opening exchanges in a trial of drugmakers' challenges to UK fines for unfair pricing kicked off. Advanz Pharma, Allergan and other drugmakers as well as private equity firms are fighting more than 260 million pounds in penalties for antitrust breaches in the supply of hydrocortisone tablets for a decade from 2008.Advanz Pharma's former top lawyer told a UK judge today that he was well versed in antitrust compliance in the opening exchanges in a trial of drugmakers' challenges to UK fines for unfair pricing kicked off....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections